These findings add to the literature by indicating that ARFID patients are commonly male or have diverse gender identities, and have high rates of neurodevelopmental, mood, anxiety, and gastrointestinal disorders. We also found high rates of PTSD. The findings show promise for treatment outcomes across the continuum of care. Next steps in ARFID treatment and research include incorporating ARFID-specific assessments into routine care, and ongoing research investigating the efficacy and effectiveness of treatments such as CBT-AR.
Keyphrases
- quality improvement
- healthcare
- end stage renal disease
- tertiary care
- palliative care
- systematic review
- newly diagnosed
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- clinical practice
- sleep quality
- peritoneal dialysis
- physical activity
- pain management
- depressive symptoms
- prognostic factors
- machine learning
- affordable care act
- congenital heart disease
- social support
- artificial intelligence
- anorexia nervosa
- smoking cessation
- patient reported